Silverarc Capital Management »

Syndax Pharmaceuticals Inc call shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Syndax Pharmaceuticals Inc call shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Syndax Pharmaceuticals Inc call

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals Inc call held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals Inc call by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $770k 50k 15.39
2025-06-30 $468k 50k 9.36
2024-12-31 $2.3M 172k 13.22

More positions owned by Silverarc Capital Management

Abivax Sa Sponsored Ads (ABVX)
Rhythm Pharmaceuticals (RYTM)
Avidity Biosciences Ord (RNA)
Nuvalent Inc-a (NUVL)
Urogen Pharma (URGN)
Akero Therapeutics (AKRO)
Insmed Com Par $.01 (INSM)
Dianthus Therapeutics (DNTH)
Uniqure Nv SHS (QURE)
Cg Oncology (CGON)
United Therapeutics Corp Del Put Put Option
Oric Pharmaceuticals (ORIC)
Cidara Therapeutics Com New (CDTX)
Fractyl Health (GUTS)
Kalvista Pharmaceuticals (KALV)

View all positions for Silverarc Capital Management

Top funds holding Syndax Pharmaceuticals Inc call

Group One Trading
Simplex Trading
Silverarc Capital Management

View all funds holding Syndax Pharmaceuticals Inc call